HIV drug resistance among adults initiating antiretroviral therapy in Uganda

Simple item page
dc.contributor.authorWatera, Christine
dc.contributor.authorSsemwanga, Deogratius
dc.contributor.authorNamayanja, Grace
dc.contributor.authorAsio, Juliet
dc.contributor.authorLutalo, Tom
dc.contributor.authorNamale, Alice
dc.contributor.authorSanyu, Grace
dc.contributor.authorSsewanyana, Isaac
dc.contributor.authorGonzalez-Salazar, Jesus Fidel
dc.contributor.authorNazziwa, Jamirah
dc.contributor.authorNanyonjo, Maria
dc.contributor.authorRaizes, Elliot
dc.contributor.authorKabuga, Usher
dc.contributor.authorMwangi, Christina
dc.contributor.authorKirungi, Wilford
dc.contributor.authorMusinguzi, Joshua
dc.contributor.authorMugagga, Kaggwa
dc.contributor.authorKatongole Mbidde, Edward
dc.contributor.authorKaleebu, Pontiano
dc.date.accessioned2021-12-18T06:46:59Z
dc.date.available2021-12-18T06:46:59Z
dc.date.issued2021
dc.description.abstractWHO revised their HIV drug resistance (HIVDR) monitoring strategy in 2014, enabling countries to generate nationally representative HIVDR prevalence estimates from surveys conducted using this methodology. In 2016, we adopted this strategy in Uganda and conducted an HIVDR survey among adults initiating or reinitiating ART. Methods: A cross-sectional survey of adults aged 18 years initiating or reinitiating ART was conducted at 23 sites using a two-stage cluster design sampling method. Participants provided written informed consent prior to enrolment. Whole blood collected in EDTA vacutainer tubes was used for preparation of dried blood spot (DBS) specimens or plasma. Samples were shipped from the sites to the Central Public Health Laboratory (CPHL) for temporary storage before transfer to the Uganda Virus Research Institute (UVRI) for genotyping. Prevalence of HIVDR among adults initiating or reinitiating ART was determined.en_US
dc.identifier.citationWatera, C., Ssemwanga, D., Namayanja, G., Asio, J., Lutalo, T., Namale, A., ... & Kaleebu, P. (2021). HIV drug resistance among adults initiating antiretroviral therapy in Uganda. Journal of Antimicrobial Chemotherapy. doi:10.1093/jac/dkab159en_US
dc.identifier.other10.1093/jac/dkab159
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/785
dc.language.isoenen_US
dc.publisherJournal of Antimicrobial Chemotherapyen_US
dc.subjectHIVen_US
dc.subjectDrugen_US
dc.subjectAdultsen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectUgandaen_US
dc.titleHIV drug resistance among adults initiating antiretroviral therapy in Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
HIV drug resistance among adults initiating antiretroviral therapy in Uganda.pdf
Size:
527.44 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences